RE: Are we a take over target2 Mar 2022 10:22
Bella sensitive post,
there are too many that don't understand how young pharma work. They won't go for take over because, big pharma can do so many other things, milestone payments, payment for trials, licensing agreements, royalties!. Why pay over the odds for something not proven? When/if everything gets approved big pharma will pay whatever the company is worth, whether that be $2bln, $5bln, $10bln. It doesn't matter, whatever they pay at that point will make them money, big pharma don't shop cheap, they shop smart and expensive!!!
No wonder the SP is so volatile when so many investors are not sophisticated enough to understand the market or what they have bought